Core Viewpoint - The stock of He Yu-B (02256) has risen over 6%, reaching a new high of 18 HKD, driven by recent share buybacks and positive financial performance [1] Group 1: Stock Performance - He Yu-B's stock price increased by 5.56% to 17.84 HKD, with a trading volume of 34.38 million HKD [1] - The company has conducted share buybacks, repurchasing 200,000 shares on August 27 and another 100,000 shares on August 28, totaling 9.545 million shares repurchased for 75.3 million HKD as of June 30, 2025 [1] Group 2: Shareholding Changes - Allianz SE increased its stake in He Yu-B from 4.81% to 5.10% as of August 15 [1] Group 3: Financial Performance - He Yu-B reported a revenue of 657 million RMB for the first half of the year, representing a year-on-year growth of 20% [1] - The net profit for the same period was 328 million RMB, showing a significant increase of 59% year-on-year [1] - The company holds a cash reserve of 2.3 billion RMB, providing a solid foundation for future research and operations [1] Group 4: Product Development - The growth is primarily attributed to the core product, ABKS021 (Pimitespib), in collaboration with Merck, which exercised its global commercialization option in the first half of 2025, paying an option fee of 85 million USD [1] - The company is expected to achieve sustainable mid-term performance as it progresses towards the global approval and commercialization of Pimitespib, along with milestone payments and revenue sharing from sales [1]

Core Insights - Allianz SE increased its stake in 和誉-B (02256.HK) by purchasing 1.957 million shares at an average price of HKD 15.6938 per share, totaling approximately HKD 30.71 million [1] - Following this transaction, Allianz SE's total shareholding in 和誉-B rose to 34.652 million shares, increasing its ownership percentage from 4.81% to 5.10% [1][2] Summary by Categories Shareholding Activity - Allianz SE acquired 1.957 million shares of 和誉-B on August 15, 2025 [1] - The average purchase price was HKD 15.6938 per share, amounting to a total investment of about HKD 30.71 million [1] Ownership Changes - Post-acquisition, Allianz SE's total shares held in 和誉-B reached 34.652 million [1] - The ownership percentage increased from 4.81% to 5.10% [1][2]

Core Insights - Eye-Net Mobile Ltd., a subsidiary of Foresight Autonomous Holdings Ltd., has completed the first phase of a significant mobility trial in Bordeaux, France, focusing on enhancing urban road safety through its V2X collision prevention technology [1][2][3] - The second phase of the trial is scheduled for the fourth quarter of 2025, involving up to 10,000 participants and testing the alert system in live urban environments [4][5] Company Overview - Foresight Autonomous Holdings Ltd. specializes in advanced 3D perception systems and has developed a V2X platform that integrates with mobile applications to provide real-time collision alerts [1][7] - Eye-Net's technology achieved a detection rate of over 99% for interactions between road users, demonstrating its effectiveness in urban settings [5][6] Collaboration and Ecosystem - The Bordeaux trial is conducted in collaboration with several partners, including Renault Group and Orange S.A., as part of the Software République initiative aimed at intelligent and sustainable mobility solutions [2][9] - The Software République is an open innovation ecosystem that combines expertise from various sectors to address challenges in connected vehicles and smart cities [10][11] Future Developments - The trial's success is seen as a testament to the scalability and reliability of Eye-Net's platform, with plans for further advancements to meet the complex demands of modern urban environments [6][12]

Core Viewpoint - Eye-Net Mobile Ltd., a subsidiary of Foresight Autonomous Holdings Ltd., is advancing urban mobility safety through its V2X collision prevention technology, with a significant trial in Bordeaux, France, and plans for a larger trial in late 2025 [1][2][4]. Group 1: Trial Details - The first phase of the Bordeaux trial involved collaboration with major partners including Renault Group and Orange S.A., focusing on enhancing road safety for urban users [2][3]. - The second phase, scheduled for the fourth quarter of 2025, will include up to 10,000 participants using a public transportation app to test Eye-Net's alert system in live urban environments [4]. Group 2: Technology Performance - Eye-Net's V2X platform achieved a detection rate of over 99% for interactions among road users, demonstrating robust interoperability with existing applications [5]. - The technology utilizes smartphones and connected vehicles to create a real-time communication network that alerts users to potential collisions, even in low visibility conditions [3][5]. Group 3: Company Commitment and Vision - The CEO of Eye-Net emphasized the trial's success as a testament to the platform's flexibility and reliability, indicating the technology's maturity and scalability for urban mobility solutions [6]. - Eye-Net aims to support the evolving demands of modern urban environments by advancing its collision prevention solutions [6][7].

Investment Ratings - European Real Estate sector is rated as "Sell" for Kojamo due to weak operating trends and high valuation [2] - Allianz has been downgraded to "Neutral" while AXA is preferred in the multi-line insurance sector [3] - Ryanair is reiterated as a "Buy" following a strong outlook for FY26 results [5][35] Core Insights - European Real Estate remains volatile, but M&A activity is increasing, with a 28% year-over-year rise in M&A volumes [2] - Allianz shares have increased by 22% since September 2024, but the stock is now trading at the high end of its historical valuation range [3] - Investors are focusing on high-quality names in the European Chemicals sector, with cautious sentiment towards Symrise and Croda [4] Summary by Sections Real Estate - M&A activity in European Real Estate is on the rise, with companies like Assura and Warehouse REIT being potential takeover targets [2] - Coverage trades at a significant 36% discount to NTA, compared to a 16% long-term average [2] Insurance - Allianz's earnings estimates for 2025 have been cut by 8%, leading to a reduced price target [3] - AXA is highlighted as a preferred multi-line insurance play due to its undemanding valuation and buyback potential [3] Chemicals - High-quality names such as Givaudan and Air Liquide are favored, while there is caution regarding Symrise and Croda due to destocking risks [4] Transportation - Ryanair's net profit estimate for FY26 has been increased by 3%, indicating a positive outlook [5] - The company is expected to benefit from share buybacks and the removal of ownership restrictions, supporting its inclusion in MSCI global indices [7]

Core Viewpoint - The previously reliable strategy of investing in U.S. stocks while holding dollars has failed, with foreign investors suffering greater losses than domestic investors, highlighting the risks associated with currency fluctuations and market volatility [2][3]. Group 1: Investment Strategy and Market Performance - The S&P 500 index has declined by 6% this year, leading to a 14% loss for investors measuring returns in euros and yen [2]. - Foreign investors are now seeking to hedge their U.S. stock investments, which were valued at approximately $18 trillion as of last December, nearly one-fifth of the total U.S. stock market capitalization [2]. - The overall currency hedging ratio for foreign investors in U.S. stocks is currently at 23%, significantly lower than nearly 50% in 2020 [3]. Group 2: Hedging Costs and Strategies - The cost of hedging against currency depreciation has increased, with three-month hedging costs for investors in Swiss francs or yen at about 4% annualized, and over 2% for eurozone investors [3][4]. - The trading volume of euro-to-dollar options has reached record highs, indicating a growing interest in hedging strategies amid increased volatility [4]. - Some investors, like those at Prevoir Asset Management, have experienced significant losses, with their funds down approximately 18% this year due to unpredictable currency fluctuations [4]. Group 3: Market Outlook and Predictions - Analysts predict that the trend of a stronger euro and weaker dollar may persist for several years, with Deutsche Bank forecasting the euro-to-dollar exchange rate to reach 1.30 by the end of 2027 [5]. - Allianz economists warn that even a small outflow of international investment from the U.S. could lead to significant distortions in exchange rates and global asset prices [5]. - Group Richelieu's strategy of hedging against currency risks has helped mitigate some losses in the U.S. stock market, with the euro rising from approximately 1.05 to over 1.15 against the dollar [5].